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Macrophages as immune cells prevent the spreading of pathogens by means of active 
phagocytosis and killing. We report here the presence of an antimicrobial protein, bac-
tericidal/permeability-increasing protein (BPI) in human macrophages, which actively 
participates in engulfment and killing of Gram-negative pathogens. Our studies revealed 
increased expression of BPI in human macrophages during bacterial infection and upon 
stimulation with various pathogen-associated molecular patterns, viz., LPS and flagel-
lin. Furthermore, during the course of an infection, BPI interacted with Gram-negative 
bacteria, resulting in enhanced phagocytosis and subsequent control of the bacterial 
replication. However, it was observed that bacteria which can maintain an active repli-
cating niche (Salmonella Typhimurium) avoid the interaction with BPI during later stages 
of infection. On the other hand, Salmonella mutants, which cannot maintain a replicating 
niche, as well as Shigella flexneri, which quit the endosomal vesicle, showed interaction 
with BPI. These results propose an active role of BPI in Gram-negative bacterial clear-
ance by human macrophages.
Keywords: innate immunity, gram-negative bacteria, macrophage evolution, bacterial niche, phagocytic receptor, 
antimicrobial protein
inTrODUcTiOn
Innate immune responses refer to the first line of non-specific defense mechanisms that get activated 
immediately upon encounter with the pathogen. Once a pathogen comes in contact with the host 
innate immune cells, various sets of genes are upregulated, whose products play an important role 
in defense mechanisms. These defense mechanisms are classically categorized as O2-dependent and 
O2-independent modes of bacterial killing. O2-dependent bactericidal activity is mediated by the 
NADPH phagocyte oxidase and inducible nitric oxide synthase pathways, whereas O2-independent 
bactericidal activity is mediated by antimicrobial peptides and proteins. Bactericidal/permeability-
increasing protein (BPI) is a 55-kDa antimicrobial protein with multiple functions including bacterial 
killing, bacterial opsonization, and LPS neutralization (1). BPI is primarily known to be expressed 
FigUre 1 | Bacterial permeability-increasing protein is expressed in 
human monocyte/macrophages. Human or mouse monocytes/
macrophages were exposed to indicated experimental conditions. Total RNA 
was extracted from (a) human and mouse monocyte and macrophage cell 
lines, (B) human peripheral blood monocytes (hPBMCs) and BPI expression 
were analyzed by semiquantitative RT-PCR. PCR products were purified and 
sent for sequencing for further confirmation. (c) Human PBMCs were PFA 
fixed and stained for BPI (red), CD11b (green), and nuclei (blue) and 
visualized by confocal microscopy.
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in human neutrophils and epithelial cells. Previous studies have 
shown that among innate immune cells, murine BPI is expressed 
only in dendritic cells and neutrophils but not in macrophages 
(2). Based on these results, no further studies have been car-
ried out to understand the expression of BPI in macrophages. 
However, murine macrophages unlike human macrophages are 
strong producers of nitric oxide and can kill invading pathogens 
by oxidative stress (3–5). We assumed that in contrast to murine 
macrophages, human macrophages in compensation for the rela-
tively weak nitric oxide production may employ stronger and more 
diverse antimicrobial protein production to restrict the spread 
of invading pathogens. To evaluate this hypothesis, we studied 
the expression of BPI in human monocytes and macrophages as 
BPI is the principal O2-independent bactericidal agent that acts 
against Gram-negative bacteria in human neutrophils (6).
In this report, we have analyzed BPI expression in murine and 
human macrophages under various inflammatory conditions. We 
investigated the potential role of BPI as an antibacterial agent in 
human macrophages. Surprisingly, we show that BPI is expressed 
in human macrophages. In addition to its role as an antibacterial 
agent, BPI expressed in human macrophages can mediate uptake 
of Gram-negative bacteria. Gram-negative bacteria which can 
maintain an active replicating niche in human macrophages 
avoid the interaction with BPI during later stages of an infection. 
Together, these results suggest an active role of BPI in Gram-
negative bacterial internalization and restricting Gram-negative 
bacterial replication in human macrophages.
resUlTs
BPi expression in human Monocytes
To understand whether BPI is differentially expressed in human 
and murine macrophages, BPI expression in murine and human 
macrophage cell lines were compared in the presence of LPS and 
PMA (Figure  1A). Surprisingly, BPI mRNA was detected in a 
human monocyte cell line under resting condition. Furthermore, 
BPI was found to be expressed in PMA stimulated U937 cells 
as well, indicating BPI expression in differentiated macrophages 
(Figure  1A). To validate BPI expression in human PBMCs, 
BPI-full length product from human PBMCs was amplified 
and sequenced (Figure  1B). Sequencing results showed >97% 
sequence identity to BPI-encoding DNA sequence (Figure S1A 
in Supplementary Material). Additionally, immunostaining with 
a BPI-specific antibody in human PBMCs revealed predominant 
localization of BPI toward cell surface (Figure 1C). CD11b stain-
ing of human PBMCs further confirmed the presence of BPI in 
human PBMCs derived macrophages as well as the colocaliza-
tion of BPI with the surface molecule CD11b (Figure 1C). These 
results suggest that BPI is expressed in human but not murine 
macrophages.
regulation of BPi expression in human 
Monocytes
To understand whether BPI expression varies during the course 
of infection, BPI expression in human monocytes was analyzed 
under different inflammatory conditions. To this end, U937 cells 
were infected with different bacteria [Salmonella Typhimurium 
(STM), Staphylococcus aureus (SA), and Salmonella Typhi (STY)] 
or were incubated with different PAMPS (LPS and flagellin): after-
ward, total RNA was isolated and BPI expression was quantified 
by real-time PCR (Figure 2A). Furthermore, in order to analyze 
the protein expression of BPI, the cells were fixed and stained 
with an anti-BPI antibody and investigated by flow cytometry 
(Figure  2C). These analyses demonstrated that the expression 
of BPI in human monocytes remained unchanged under all the 
tested inflammatory conditions.
Bactericidal/permeability-increasing protein is known to be 
released into inflammatory exudates (7). To understand whether 
BPI is secreted by human monocytes or macrophages, U937 cells 
were PMA stimulated or infected with different pathogens (STM 
and STY). Cell culture supernatant was collected 24  h, post-
treatment, and BPI levels were determined by ELISA (Figure S1B 
in Supplementary Material). There was no detectable level of BPI 
in cell culture supernatant, indicating that BPI is not secreted by 
human monocytes or macrophages.
regulation of BPi expression  
in Differentiated Macrophages
Differentiation of monocytes to macrophages is known to induce 
an inflammatory and antibacterial response in macrophages (8). To 
determine whether the increased antibacterial activity of human 
macrophages is due to increased expression of BPI, U937 cells 
were differentiated into macrophages by treating monocytes with 
PMA (50 nM) for 24 h. As expected, differentiated macrophages 
FigUre 2 | regulation of BPi expression in human monocytes/macrophages. U937 monocytes/macrophages were exposed to indicated inflammatory 
stimuli/pathogen. (a,B) Total RNA was isolated and BPI expression was investigated by real-time PCR [n = 5 (SD)]. (c) BPI expression was checked by flow 
cytometry [n = 3 (SD)]. (D) Total protein was isolated from U937 macrophage, and BPI levels were analyzed by western blot (n = 4). Bottom: quantitative evaluation 
of the relative BPI expression normalized to β-actin intensity. (e) Cells were PFA fixed and stained for BPI (red) and nuclei (blue). Cells were imaged by confocal 
microscopy (n = 6). Key: ***p < 0.001, **p < 0.005, *p < 0.05; ns, not significant.
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showed an increased antibacterial activity toward STM compared 
to U937 monocytes (Figure S2B in Supplementary Material). 
Interestingly, BPI mRNA expression significantly increased in 
differentiated macrophages upon treatment with various PAMPs 
(LPS and flagellin) or infection with various pathogens (STM, STY, 
and SA) (Figure 2B). BPI expression was increased up to three-
fold in the presence of flagellin compared to untreated control. In 
contrast, the BPI expression remained unchanged in the presence 
of LPS. To evaluate the contribution of flagellin in inducing BPI 
expression, U937 macrophages were incubated with heat-killed 
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strains of STM [flagellin-deficient Salmonella Typhimurium 
14028 (STM ΔfliC)] and a non-motile Gram-positive pathogen 
(SA). Heat-killed STM showed increased BPI expression when 
compared to either untreated controls or HK STM ΔfliC and 
live bacteria. Nevertheless, BPI expression was significantly 
increased by STM ΔfliC and SA compared to untreated control. 
These results indicate that several PAMPs other than flagellin can 
also contribute to the BPI expression during infection. Under 
uninfected conditions, there was no significant increase in BPI 
mRNA expression in differentiated macrophages compared to 
U937 monocytes (Figure S2A in Supplementary Material).
In order to evaluate BPI expression at the protein level, U937 
macrophages were incubated in the presence of various PAMPs 
(LPS and flagellin) and bacteria (STM) for 24 h. Thereafter, the 
cells were fixed and the BPI expression was checked by flow 
cytometry as well as confocal microscopy (Figures  2C,E). BPI 
expression was significantly increased in the presence of bacteria 
as well as PAMPs. LPS induced BPI expression at the protein 
level, even though there was no significant induction at the RNA 
level. Western blot analysis showed 2.5-fold increase in BPI 
expression after LPS treatment and 4.5-fold after flagellin treat-
ment (Figure 2D). These results confirm that BPI is induced in 
differentiated macrophages during the course of infection.
BPi enhances Bactericidal activity  
of human Macrophages
Bactericidal/permeability-increasing protein is known to inhibit 
the growth of Gram-negative bacteria (9). In order to understand 
whether BPI expressed in U937 macrophages is functionally 
active, an antibacterial assay was carried out. U937 macrophages 
were treated with various PAMPs, which were shown to induce BPI 
expression (LPS 100 ng and flagellin 500 ng). Twenty-four hours 
post-treatment, cells were infected with STM 14028 at a multiplic-
ity of infection (MOI) of 10. Bacterial replication was quantified 
by plating cell lysates 2 and 16 h post-infection. Conditions which 
induced BPI expression significantly affected bacterial growth 
in U937 macrophages (Figure S3 in Supplementary Material). 
To understand the contribution of BPI in inhibiting bacterial 
growth, bacterial replication was assessed after knocking down 
BPI in U937 macrophages. To knock down BPI, U937 mac-
rophages were transfected with BPI dsRNA. Twenty-four hours 
post-transfection, cells were infected with STM 14028 at MOI of 
10. The efficacy of BPI knockdown in dsRNA transfected cells 
was validated by western blot analysis (Figure 3C) and confocal 
microscopy (Figure S4 in Supplementary Material). Bacterial 
replication was quantified by plating cell lysates 2 and 16  h 
post-infection (Figure  3A). Bacterial replication significantly 
increased in cells where BPI expression was strongly reduced due 
to dsRNA knockdown compared to untransfected controls. To 
confirm that BPI expressed in primary human macrophages can 
inhibit bacterial replication, bacterial replication was assessed 
in primary human PBMCs after knocking down BPI. Bacterial 
replication significantly increased in BPI low expressing cells due 
to dsRNA transfection compared to scrambled dsRNA control 
(Figure 3B). These data show that BPI contributes significantly in 
limiting bacterial replication in human macrophages.
Antibacterial activity of BPI is specific toward Gram-negative 
bacteria due to the specific interaction between BPI and 
Gram-negative bacterial LPS (6, 10). To validate the specific-
ity of BPI knockdown, Gram-positive bacterial replication 
was assessed after knocking down BPI in U937 macrophages. 
U937 macrophages were transfected with BPI dsRNA; 24-h 
post-transfection, cells were infected with S. aureus at an MOI 
of 10. Bacterial replication was quantified by plating infected cell 
lysates after 2 and 16 h post-infection (Figure 3A). Replication 
of S. aureus remained unaffected after knocking down BPI in 
U937 macrophages indicating the specificity of BPI activity to 
clear Gram-negative pathogens in human macrophages. In order 
to understand the importance of human BPI in inhibiting bacte-
rial replication, human BPI was amplified from macrophages 
by PCR, cloned, and expressed in murine macrophages lacking 
endogenous BPI. Expression of human BPI in RAW 264.7 cells 
was confirmed by western blotting (Figure 3E). Overexpression 
of human BPI in murine macrophages increased their antibac-
terial activity, suggesting that human BPI expressed in human 
macrophages significantly contributes in bacterial killing 
(Figure  3D). These results suggest that human BPI actively 
contributes to the clearance of Gram-negative bacteria in 
macrophages.
BPi Mediates Phagocytic Uptake  
of gram-negative Bacteria by human 
Macrophages
In 1997, the role of BPI as an opsonin in human neutrophils was 
published (11). We observed a significant interaction of surface 
BPI with Gram-negative bacteria during early time points of 
infection (Figure  4A). Interestingly, flow cytometry analysis 
and confocal microscopic analysis of non-permeabilized U937 
macrophages showed the presence of BPI on the cell surface. 
Furthermore, the cell surface-associated BPI interacted clearly 
with STM (Figure S5 in Supplementary Material). Based on 
these observations, we hypothesized that BPI expressed on 
human macrophages might act as a receptor that enhances the 
phagocytic activity of macrophages toward Gram-negative bac-
teria. To validate this hypothesis, phagocytosis of Gram-negative 
bacteria by macrophages was quantified after knocking down 
BPI in U937 macrophages. U937 macrophages were transfected 
with BPI dsRNA; 24-h post-transfection, cells were infected with 
STM 14028 at MOI of 10. Thereafter, phagocytosis of STM 14028 
by macrophages was calculated by plating the macrophage cell 
lysate 30 min post-infection (Figure 4B). We found that the uptake 
of STM 14028 was significantly decreased upon BPI knockdown 
in U937 macrophages compared to untransfected control. 
Interestingly, BPI knockdown did not affect uptake of S. aureus 
(Gram-positive bacteria) by U937 macrophages (Figure 4B). To 
confirm the role of BPI in Gram-negative bacterial phagocytosis 
by primary human macrophages, bacterial phagocytosis was 
assessed in human PBMCs after knocking down BPI. Bacterial 
uptake was significantly affected upon BPI knockdown in mac-
rophages derived from human PBMCs (Figure 4C). These results 
suggest that surface expressed BPI contributes significantly in 
Gram-negative bacterial phagocytosis by human macrophages.
FigUre 3 | human macrophages expressed BPi and kills intracellular bacteria. (a) Fold proliferation and percentage survival of bacteria after knocking 
down of BPI in U937 macrophages. Statistical significance was calculated with respect to untransfected control [n = 5 (SD)]. (B) Fold proliferation of STM after 
knocking down of BPI in human PBMCs-derived macrophages. Statistical significance was calculated with respect to scrambled dsRNA-transfected control [n = 6 
(SD)]. (c) Total protein was isolated from BPI dsRNA-transfected and untransfected control U937 macrophages, and BPI levels were checked by western blot 
(n = 3). (D) RAW 264.7 macrophages were transfected with either pcDNA empty vector (pcDNA EV) or pcDNA carrying the expression sequence of human BPI 
(pcDNA hBPI). Twenty-four hours post-transfection, the cells were infected with STM and bacterial proliferation was quantified [n = 4 (SD)]. (e) Total protein was 
isolated from pcDNA EV-transfected and pcDNA hBPI-transfected RAW 264.7 macrophages, and BPI levels were quantified by western blot (n = 3). Key: 
***p < 0.001, **p < 0.005, *p < 0.05; ns, not significant.
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FigUre 4 | BPi enhances bacterial uptake in human macrophages. (a) U937 macrophages were infected with STM–GFP (green) at an MOI of 10. Thirty 
minutes post-infection, cells were fixed with paraformaldehyde and stained for BPI (red) and nuclei (blue) (n = 4 experiments). (B,D) Percentage phagocytosis of 
bacteria after knocking down of BPI in U937 macrophages. U937 macrophages were infected with the indicated bacteria at an MOI of 10. Bacterial entry was 
quantified by plating cell lysates after 30 min post-infection [n = 6 (SD)]. For experiments with Salmonella Typhi (STY), percentage phagocytosis of BPI dsRNA 
transfected cells was compared to untransfected control and was normalized to STY (WT). (c) Percentage phagocytosis of STM in hPBMC-derived macrophages. 
Statistical significance was calculated with respect to scrambled dsRNA-transfected control [n = 6 (SD)]. Key: ***p < 0.001, **p < 0.005, *p < 0.05; ns, not 
significant.
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Many pathogenic bacteria are known to possess outer membra-
nous structures that help to evade phagocytosis by macrophages. 
STY has Vi-polysaccharide that resists opsonophagocytosis medi-
ated by complement receptors (12). The Vi-polysaccharide is also 
known to inhibit the TLR4-mediated innate immune response 
(13). BPI and TLR4 recognize lipid A moieties on the surface of 
bacteria (14). We hypothesized that the presence of Vi capsular 
polysaccharide might inhibit BPI-mediated phagocytosis of STY. 
In order to understand the importance of Vi-polysaccharide in 
BPI-mediated phagocytosis, we checked the percentage phagocy-
tosis of Vi-negative Salmonella Typhi (STY Vi−) by macrophages 
in the presence or absence of BPI. BPI was knocked down in 
U937 macrophages as explained above. U937 macrophages were 
infected with STY, STY Vi−, and STY ΔpmrDG. Percentage 
phagocytosis was calculated by plating the cell lysate 30 min 
post-infection. Percentage phagocytosis was significantly higher 
for Salmonella devoid of Vi-polysaccharides (STY Vi−) compared 
to STY, but bacterial phagocytosis was significantly decreased 
irrespective of the presence or the absence of Vi polysaccharide 
after knocking down BPI in human macrophages (Figure 4D). 
STY ΔpmrDG was used as a negative control in this experiment 
as the pmr operon is important for structural modifications in 
LPS but is not important for preventing phagocytosis by mac-
rophages [Figure 4D; (15)]. These results suggest that capsular 
polysaccharide, although very important to inhibit phagocytosis 
by macrophages, in general, will not affect the BPI-mediated 
phagocytosis of Gram-negative bacteria.
Salmonella Typhimurium evades  
BPi interaction during later stages  
of infection
We next analyzed the intracellular interaction of BPI with STM 
by confocal microscopy during the course of infection. Therefore, 
U937 macrophages were infected with STM14028 at an MOI of 
50 and bacterial colocalization with BPI at different time points 
was analyzed. A region of interest (ROI) was drawn around 
each bacterium based on GFP signal and % colocalization of 
a bacterium and BPI at ROI was quantified. STM showed sig-
nificantly higher colocalization with BPI at early time points of 
infection (15 min to 1 h). Interestingly, during later time points 
of infection (2–6 h) by which bacteria maintain a proper niche 
inside the macrophages, Salmonella-containing vesicles (SCVs), 
a significant lesser colocalization with BPI, could be observed 
(Figure 5A). The time course of STM replication in macrophages 
with knocked down BPI showed that STM replication was higher 
in knocked down conditions within 6 h post-infection compared 
to untransfected controls. These data are in accordance with pre-
vious reports, which suggest that replication of STM takes place 
starting 6  h post-infection by which the bacteria maintain an 
actively replicating niche inside the macrophage (16) (Figure 5B). 
STM replication was significantly higher in BPI KD conditions 
from 6 to 24 h compared to untransfected control, even though 
we see a significant decrease in the bacterial entry in BPI KD cells 
compared to untransfected controls (Figure 5C).
We next tried to understand the importance of maintaining 
an actively replicating niche by STM (SCV) to avoid interaction 
with BPI in human macrophages. U937 macrophages were 
infected with GFP-tagged bacteria, either replicating STM, 
paraformaldehyde fixed STM (PFA STM), Escherichia coli DH5α 
(which cannot replicate inside macrophages), or Shigella flexneri 
(SHG; which quits endosomal vesicle). Two hours post-infection, 
the cells were fixed and the interaction of BPI with the bacteria 
was analyzed by confocal microscopy (Figure 6A). Recruitment 
of BPI to the bacteria was analyzed by two methods. First, we 
checked the interaction of BPI with the bacteria by analyzing the 
percentage colocalization of BPI and GFP at ROI as explained 
above (Figure  6B). Second, we analyzed the mean fluorescent 
intensity (MFI) of BPI at ROI to understand the recruitment of 
BPI to the bacteria (Figure 6C). There was a significant increase 
in the recruitment of BPI measured by MFI as well as % colo-
calization of BPI with PFA STM compared to STM. This may 
indicate that Salmonella actively inhibits the recruitment of BPI 
to SCV during later stages of infection. Bacteria which cannot 
replicate inside macrophages (E. coli) and bacteria which quit the 
endosomal vesicle (SHG) showed significantly higher interaction 
with BPI compared to STM (Figures 6A–C). BPI was found to be 
localized along the surface of SHG (Figure 6A, inset). In order to 
evaluate the survival of SHG in human macrophages, we checked 
the entry as well as the replication of SHG in human macrophages 
after knocking down BPI as explained above. SHG entry signifi-
cantly decreased in U937 macrophages upon knockdown of BPI 
compared to untransfected control (Figure  4B). Interestingly, 
SHG which usually gets cleared in human macrophages was able 
to replicate in human macrophages upon knockdown of BPI 
(Figure 3A). Percentage survival was calculated by normalizing 
bacterial CFU from 18 h to the CFU count 2 h post-infection. 
SHG percentage survival was increased from 50 to 150% indicat-
ing the importance of BPI in clearing cytosolic bacteria in human 
macrophages. BPI levels were detected by western blotting after 
infection with STM, SHG, and E. coli in U937 macrophages 
(Figure S6 in Supplementary Material). There was no significant 
difference in BPI levels in STM infected cells compared to SHG 
infected cells. These results indicate that the differential interac-
tion of BPI with STM and SHG is not due to differential expres-
sion or degradation of BPI.
Salmonella Typhimurium Maintains an 
actively replicating niche in Order to 
evade BPi interaction
Salmonella Typhimurium is known to maintain an actively 
replicating niche inside the macrophage by modifying the 
endosomal membrane, thereby preventing their fusion with the 
late lysosome (SCV) (16). SCV actively modifies its membrane-
associated proteins, and these modifications are important for 
the survival of STM in macrophages. In our present study, we 
observed that BPI interacts significantly stronger with cytosolic 
bacteria (SHG) and PFA-fixed STM compared to live STM. These 
observations led us to hypothesize that SCV might actively avoid 
the interaction of BPI with the bacteria inside macrophages. 
To  evaluate this hypothesis, we checked the interaction of BPI 
with STM ΔsifA, a Salmonella mutant, which cannot maintain an 
actively replicating niche (SCV) (17). Two hours post-infection, 
FigUre 5 | Time-course analysis of BPi interaction with Salmonella Typhimurium in U937 macrophages during the course of infection. (a) U937 
macrophages were infected with STM–GFP (green) at an MOI of 50. Cells were fixed with PFA at the indicated time points and stained for BPI (red) and nuclei (blue) 
(n = 3). Panel shows representative bright field and merged images for each time point. (B) Quantification of colocalization of BPI with STM–GFP [n = 3 (SD)]. 
(c) U937 macrophages were infected with STM–GFP at an MOI of 10. Bacterial entry was quantified by plating the cell lysates after 30 min post-infection. Bacterial 
replication was quantified by plating the cell lysates at indicated time points and was normalized to the CFU at 1 h post-infection. Fold proliferation and percentage 
survival were calculated [n = 3 (SD)]. Key: ***p < 0.001, **p < 0.005, *p < 0.05; ns, not significant.
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FigUre 6 | BPi interaction with gram-negative bacteria inside macrophages. 
(Continued)
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cells were fixed, bacteria and cells were stained with DAPI. An 
ROI was drawn around each bacterium marked upon DAPI 
staining (Figures 7A,B). MFI of BPI as well as % colocalization of 
BPI and bacteria was evaluated at ROI (Figures 7C,D). LAMP 2 
was used as a marker to confirm whether STM ΔsifA maintains in 
an intracellular vesicle or not (Figures 7A,B). STM ΔsifA mostly 
remained in the cytoplasm compared to STM wild type, which 
was in LAMP2-positive compartments as analyzed by LAMP2 
colocalization (Figure  7E). STM ΔsifA showed an increased 
colocalization with BPI compared to STM wild type, indicating 
FigUre 6 | continued  
(a) U937 macrophages were infected with GFP-tagged (green) Gram-negative bacteria [STM14028, PFA fixed STM, E. coli DH5α, and Shigella flexneri (SHG)] at an 
MOI of 50. Two hours post-infection, cells were fixed with PFA and stained for BPI (red) and nuclei (blue). White arrows indicate GFP-positive bacteria. The boxed 
area in the SHG infected set is magnified to view BPI around the bacteria (n = 3). (B) Quantification of colocalization of BPI with the bacteria. (c) Quantification of 
MFI of BPI at ROI was done by the Zen Blue edition software provided by Zeiss [n = 3 (SD)]. Key: ***p < 0.001, **p < 0.005, *p < 0.05.
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the importance of the vacuolar life of Salmonella in maintaining 
a replicative niche devoid of BPI inside macrophages. STM ΔsifA 
showed an increased recruitment of BPI around the bacteria 
measured by evaluating MFI as well as the percentage colocaliza-
tion at ROI (Figures 7C,D).
To confirm these results, we checked bacterial interaction 
with BPI under conditions which make bacteria quit the vesicle. 
To attain this, we expressed listeriolysin (LLO) in STM. LLO is 
known to make pores into vesicular membranes, which lead to 
the rupturing of the membrane (18). LLO expression was induced 
in STM LLO using IPTG. U937 macrophages were infected with 
STM EV (empty vector) or STM LLO. Two hours post-infection, 
cells were fixed and bacteria and cells were stained with DAPI 
(Figures 7F,G). An ROI was drawn around each bacteria marked 
upon DAPI staining. MFI of BPI, as well as % colocalization 
of BPI and bacteria, was evaluated at ROI. BPI and STM LLO 
colocalized significantly higher compared to STM EV as seen by 
increased % colocalization in STM LLO in comparison to STM 
EV (Figure 7H). Recruitment of BPI as measured by checking the 
MFI at ROI was also higher in STM LLO compared to STM EV 
(Figure 7I). Under these conditions, STM LLO showed a twofold 
decrease in bacterial proliferation compared to STMEV control 
(Figure S7 in Supplementary Material). These results suggest 
that STM avoids interaction with BPI by maintaining an actively 
replicating niche (SCV) inside macrophages.
DiscUssiOn
Bactericidal/permeability-increasing protein is known to be 
expressed in human neutrophils, epithelial cells, eosinophils, 
and the genital tract (1). Previous studies by Buurman et  al. 
(19) suggested the expression of BPI in human monocytes, but 
the experimental evidence clearly did not prove whether BPI is 
expressed in human monocytes or whether BPI is adsorbed on to 
the monocyte surface. In this current study, we clearly demon-
strate the expression of BPI in human macrophages both at RNA 
and protein levels. Interestingly and in sharp contrast, under 
similar conditions, we could not detect BPI expression in murine 
macrophages. The reactive nitrogen species (RNS)-mediated 
antibacterial activity of human macrophages is still a contro-
versy (20). On the one hand, there are reports which suggest 
that unlike murine macrophages, human macrophages cannot 
produce RNS (5). On the other hand, RNS could be detected in 
human macrophages isolated from PBMCs of infected patients. 
Regardless these reports, in summary, suggest that NO produc-
tion by human macrophages is either extremely low or requires 
complex signaling mechanisms for induction (4, 5). Our results 
on the expression of BPI only in human macrophages suggest that 
human macrophages during the course of evolution might have 
obtained a strong bias toward O2-independent mechanisms to kill 
pathogens as exemplified by BPI. This might give an advantage to 
the host to avoid free radical-mediated damage to the host cells 
associated with reactive nitrogen species produced during infec-
tion and in circumstances when oxygen tension is low.
Differentiation of monocytes to macrophages is known to 
increase the antibacterial activity of human macrophages (8). The 
precise mechanistic aspects of increased antibacterial activity of 
differentiated macrophages are not known. In our current study, 
we show that BPI expression is increased in differentiated mac-
rophages upon bacterial infection, whereas in undifferentiated 
monocytes, there was no significant increase in BPI expression. 
Interestingly, knocking down of BPI in macrophages led to the 
proliferation of three different strains of Gram-negative bacteria 
tested, but did not affect proliferation of S. aureus. The signal-
ing pathways that lead to BPI induction in human macrophages 
are not clear. In our study, we saw that all the PAMPs tested can 
induce BPI expression. These results show that BPI might be 
induced as a general antimicrobial protein during the infection 
by any pathogen in macrophages. Interestingly, LPS increase BPI 
protein level without changing the BPI mRNA level. This might 
be due to an increase in the stability of BPI mRNA mediated by 
MyD88 signaling pathway (21).
Previous results by Weiss and group demonstrated that BPI 
secreted by neutrophils can act as an opsonin and can induce 
opsonophagocytosis by macrophages (11). We could not detect 
BPI secreted by human macrophages upon infection. Interestingly, 
most of the BPI expressed in human macrophages is present 
on the cell surface. During the early stages of infection, BPI 
FigUre 7 | sTM avoids interaction with BPi inside macrophages by maintaining an actively replicating niche (scV). 
(Continued)
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FigUre 7 | continued  
U937 macrophages were infected with (a) STM, (B) STM ΔsifA, (F) STM EV (empty vector), or (g) STM LLO at an MOI of 50. Two hours post-infection, the cells 
were fixed with PFA at the indicated time points and stained for BPI (red) and LAMP2 (green). Nuclei and bacteria were labeled with 4′,6-diamidino-2-phenylindole 
(DAPI) (blue). White arrows indicate DAPI-positive bacteria. The boxed area in each set is magnified to view BPI around the bacteria. (c,h) Quantification of 
colocalization of BPI with bacteria. (D,i) Quantification of MFI of BPI at ROI. (e) Quantification of colocalization of LAMP2 with bacteria at ROI. All images were 
quantified by using the Zen Blue edition software provided by Zeiss [n = 3 (SD)]. Key: ***p < 0.001, **p < 0.005.
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significantly interacted with Gram-negative bacteria (Figure 5B). 
Knocking down of BPI in human macrophages led to a reduced 
entry of Gram-negative bacteria. These results may suggest 
that apart from acting as an opsonin, BPI expressed on the cell 
surface can itself act as a receptor for binding of Gram-negative 
bacteria. Whether this binding can itself induce phagocytosis or 
whether BPI helps the bacteria to adhere to macrophages and 
other phagocytic receptors distinct from the interaction with BPI 
can induce phagocytosis of bacteria is not clear. Recently, a report 
by Casanova et al. showed that GPCR brain-specific angiogenesis 
inhibitor 1 (BAI 1) can act as a receptor for the uptake of Gram-
negative bacteria and can also induce bacterial killing by indirect 
means (22). BPI may also act as a phagocytic receptor, but unlike 
BAI 1, BPI itself can act as a direct bactericidal agent. Irrespective 
of the presence or absence of capsular material, BPI can induce 
phagocytosis of Gram-negative bacteria as seen by phagocytosis 
of Vi-positive S. Typhi. How antimicrobial peptides and proteins 
can interact with LPS of capsulated bacteria is still not clear. We 
believe that the extensions of LPS outside capsular polysaccharide 
might act as a docking site for BPI (11). Whether BPI can interact 
with the capsular polysaccharide itself is something that should 
be explored in the future. Since BPI-mediated phagocytosis did 
not need any opsonin, it will be interesting to check the level of 
BPI in macrophages which are present in opsonin poor environ-
ment (e.g., alveolar macrophages). BPI significantly interacted 
with STM during early time points of the infection. During later 
time points of the infection, STM avoids BPI interaction during 
later time points and thereby maintains an actively replicating 
niche inside macrophages. Bacteria which cannot maintain an 
actively replicating niche (SHG, E. coli) will be cleared easily by 
the macrophages. All these bacteria tested showed significant 
colocalization with BPI during later time points of infection as 
well. Interestingly, SHG which cannot multiply in human mac-
rophages started multiplying in BPI knockdown macrophages. 
Confocal analysis showed the presence of BPI around SHG dur-
ing later time points of the infection indicating the importance 
of BPI in controlling Shigella. Interestingly, once the actively 
dividing bacteria (STM) leaves the replicating niche (STM LLO, 
STM ΔsifA), they will interact with BPI. These results demon-
strate an active role of BPI in eliminating Gram-negative bacterial 
pathogens inside macrophages. Whether BPI can cross talk with 
other signaling pathways and can induce additional bactericidal 
activity is not entirely clear. It will be interesting to analyze the 
contribution of macrophage-derived BPI in preventing various 
infectious diseases including parasitic and bacterial infections. 
Polymorphisms in BPI are associated with different inflammatory 
diseases, including Crohn’s disease (CD) (23–25). Macrophages 
derived from patients with CD show impaired bacterial clearance 
(26, 27). Whether this impaired clearance of bacteria is due to 
polymorphisms of BPI in macrophages derived from CD patients 
is yet to be understood.
MeThODs
cell culture
The human monocyte cell line U937 (NCCS, Pune) and murine 
macrophage cell line RAW 264.7 (kind gift from Prof. Anjali 
Karandae, IISc) were maintained in RPMI (Sigma-Aldrich) con-
taining 10% FBS (fetal bovine serum, Gibco). For induction of 
macrophage differentiation, cells were seeded and stimulated with 
50-nM PMA (phorbol 12-myristate 13-acetate, Sigma-Aldrich) 
for 24 h. After PMA induction, non-attached cells were removed 
by gentle aspiration and attached cells were washed three times 
with RPMI containing 10% FBS.
Knockdown of BPi in human 
Macrophages
In order to knock down BPI in human macrophages, BPI 
dsRNA was designed against three regions within the gene: (a) 
GGAGCTGAAGAGGATCAAGATTCCTGACTACTCAGA 
CAGCT T TAAGATCAAGCATCT TGGGAAGGGGCA 
T TATAG C T T C TAC AG C AT G G AC AT C C G T G A AT T 
C C A G C T T C C C A G T T C C C A G A T A A G C A T G G T 
G C C C A AT G T G G G C C T TA A G T T C T C C AT C A G C 
AACGCCAATATCAAGATC; (b) TGTCCACGTGC ACATCT 
CAAAGAG CAAAGTCGGGTGGCTGAT CCAACTCTTCCA 
CAAAAAAATTGAGTCTGCGCTTCGAAAC AAGATGAACA 
GCCAGGTCTGCGAGAAAGTGACCAAT TCTGTATC 
C T C C A AG C T G C A AC C T TAT T T C C AG AC T C T G C ; 
and (c) GGGTCTTGAAGATGACCCTTAGAGATGACATGA 
T T C C A A A G G A G T C C A A A T T T C G A C T G A C A 
ACCAAGTTCTTTGGAACCTTCCTACCTGAGGTGGCC 
AAGAAGTTTCCCAACATGAAGATACAGATCCATGT 
CTCAGCCTCCACC. All dsRNA were obtained from chromous 
biotech. Transfection was done using oligofectamine as recom-
mended by the manufacturer (Invitrogen, Life Technologies). 
Transfection was done for 24 h.
cloning and expression of human  
BPi in Murine Macrophages
The complete BPI coding sequence was amplified from 
cDNA derived from human monocytes. PCR product was 
gel eluted and was cloned in pcDNA 3.1 expression vector 
(kind gift from Dr. G. Subbha Rao, IISc). The pcDNA 3.1 
hBPI was transiently transfected to RAW macrophages using 
PEI transfection reagent (Sigma-Aldrich). Twenty-four hours 
post-transfection, cells were harvested and BPI expression was 
quantified by western blotting. Transiently transfected cells 
were used for infection assay. pcDNA 3.1 was used as empty 
vector control in all the experiments. The sequence for cloning 
primers is as follows: hBPI forward primer, 5′AAGGATCCA 
TGAGAGAGAACATGGCC3′, and hBPI reverse primer, 
5′GGCAAGCTTTCATTTATAGACAACGTC3′. The restric-
tion sites within the primers are underlined.
Bacterial strains and growth conditions
Salmonella Typhimurium (Salmonella enerica serovar 
Typhimurium ATCC14028s), STM ΔfliC (flagellin-deficient 
STM 14028), STY (STY ATCC CT18), SHG (SHG clinical isolate 
1), SA (SA ATCC 25923), and E. coli (E. coli DH5α ATCC) were 
grown in Luria-Bertani medium at 37°C. STM ΔsifA and STM 
ΔfliC was a gift from Michael Hensel, Universität Osnabrück, 
Germany. For immunostaining experiment STM, SHG and E. 
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coli were transformed with the pFPV25.1 plasmid containing 
the GFPmut3 gene (Addgene). In order to express listeriolysin O 
in STM, STM 14028 was transformed with pPROEX HT-b LLO 
(STM LLO). STM 14028 transformed with pPROEX HT-b (STM 
EV) was used as empty vector control. pPROEX HT-b LLO was a 
kind gift from Prof Sandhya S. Visweswariah, IISC. All the trans-
formants were maintained in Luria-Bertani medium containing 
100 μg/ml of ampicillin. For induction of LLO expression in STM 
LLO, log phase cells were treated with 500-nM IPTG (Sigma-
Aldrich) for 6 h. STY Vi− (STY lacking Vi polysaccharide) was a 
kind gift from Prof Ayub Qadri, NII.
immunofluorescence Microscopy
U937 cells were seeded on glass coverslips overnight before 
infection or treatment. After treatment, cells were washed with 
PBS and fixed with 3.5% paraformaldehyde for 15 min. Cells 
were permeabilized using 1% saponin (Sigma-Aldrich) dis-
solved in PBS with 3% BSA. Immunostaining was done using 
anti-BPI antibody (Sigma-Aldrich) followed by anti-rabbit 
Alexa 647 antibody (DSHB, University of Iowa). To visualize 
macrophage population in human PBMC cultures, cells were 
stained with the anti-CD11b antibody (DSHB, University of 
Iowa) followed by anti-mouse Alexa 488 antibody (DSHB, 
University of Iowa). To label lysosomes, anti-LAMP2 antibody 
(DSHB, University of Iowa) was used followed by anti-mouse 
Alexa 488 antibody (DSHB, University of Iowa). Cells were 
counterstained using DAPI (Sigma-Aldrich) to label the 
nucleus. To visualize bacteria, either pFPV25.1 GFPmut3-
transformed bacteria were used or bacteria were visualized 
using DAPI staining. Image acquisition was done with a 
Zeiss confocal microscope (LSM Meta 710). Quantitation of 
images was done as explained by Billings et  al. (22). Briefly, 
for quantification of BPI recruitment and interaction with bac-
teria, an ROI was drawn around each bacterium based upon 
GFP signal (STM–GFP, SHG–GFP, and E. coli GFP) or DAPI 
staining (STM ΔsifA, STM LLO, and STM EV). Images were 
analyzed using Zen Blue edition software provided by Zeiss. 
The colocalization coefficient values at ROI were obtained 
using Zen Blue edition software and were multiplied by 100 to 
get the percent colocalization and plotted. The MFI of BPI at 
ROI was calculated Zen software and plotted.
Bacterial Phagocytic Uptake and 
Proliferation assay
Bacteria were grown in Luria-Bertani medium, and overnight 
culture was used to infect U937 cells at a ratio of 10 bacteria 
per cell (MOI 10). Extracellular bacteria were removed 30 min 
post-infection, and cells were maintained in 100  μg/ml gen-
tamycin for 1 h to kill any extracellular bacteria. Infected cells 
were maintained in DMEM containing 10 μg/ml of gentamycin. 
Phagocytosis of bacteria by macrophages was calculated by 
plating the  macrophage cell lysates 30 min post-infection. For 
calculating the percentage phagocytosis, CFU was normalized 
with respect to untransfected control. The obtained value was 
multiplied by 100 to get percentage phagocytosis.
 
% ( )Phagocytosis CFUof Test / CFUof Untransfected control
       
=
                       ×100  
Bacterial replication inside macrophages was quantified by 
plating the cell lysates 2- and 18-h post-infection. Fold prolifera-
tion was calculated by normalizing the bacterial CFU at 18 h with 
respect to 2 h. For experiments using SHG, the bacterial survival 
was calculated instead of fold replication because SHG cannot 
proliferate inside macrophages.
 
Fold proliferation CFUof bacteria at h= 18
                                 / CFUof bacteria at h2  
 
% ( ) ( / )Survival
               
SHG CFUof SHGat h CFUof SHGat h= 2 18
                 ×100  
infection and stimulation of human 
Macrophages
For stimulation with various inflammatory mediators, PMA-
treated U937 cells were incubated with STM LPS 100  ng/
mL (Sigma-Aldrich) and STM flagellin 500  ng/mL in DMEM 
containing 10% FBS for the indicated time periods. Flagellin 
was isolated from STM as previously described in details (28). 
U937 monocyte cell line was used as a control throughout the 
experiment.
human PBMc isolation
This study was approved by Institutional Biosafety guidelines 
(IBSC) at Indian Institute of Science, Bangalore, India (Ref No: 
IBSC/IISC/DC/04/2015), and written informed consent was 
obtained from all participants before participation. All the pro-
cedures were carried out by trained medical technician. Human 
PBMCs were isolated from healthy individuals using Himedia 
LSM as per instructors manual. Briefly, blood collected from 
healthy individuals were overlaid on LSM and separated into 
different layers using a low-speed centrifugation. The cell layer 
containing human PBMCs was collected after centrifugation and 
mixed with DMEM without serum. Cells were seeded into a six-
well plate, and unattached cells were gently aspirated. Attached 
cells were washed three times with DMEM containing 10% FBS 
and maintained in the same for 24 h.
Pcr and real-time analysis of BPi mrna 
expression
Total RNA was extracted from 1 × 106 cells using TRIzol reagent 
(Invitrogen) as per the manufacturer’s protocol. After DNase 
treatment, 2  μg of RNA was used for cDNA synthesis using 
tetra-reverse transcriptase (Bioline). qRT-PCR was performed 
using the Kapa SYBR Green RT-PCR kit (Kapa Biosystems) 
as per the manufacturer’s protocol in an Applied Biosystems® 
ViiA™ 7 Real-Time PCR instrument. The following prim-
ers were used for detecting BPI level by real-time PCR: hBPI 
forward primer, 5′ATGAACAGCCAGGTCT 3′, and hBPI 
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